A 42-year-old woman was referred for investigation of possible phaeochromocytoma. One year previously she had an episode of hypertension and tachycardia following a routine bladder operation. Since that time she suffered episodic palpitations and hypertension, her blood pressure (BP) reaching 200/150 mm Hg on one occasion. She had undergone extensive investigations, including having several normal measurements of plasma noradrenaline, adrenaline and dopamine and normal 24-h urinary vanillylmandelic acid (VMA), metanephrines and catecholamines, on one occasion immediately following an attack. Typical attacks, lasting about 10 mins, consisted of flushing, palpitations, anxiety, sweating, a choking sensation, dry mouth and polyuria. Attacks were more frequent pre-menstrually and could be precipitated by stimuli including smells, coffee, alcohol and massage. Routine examination was unremarkable. She was normotensive (129/74 mm Hg) with no postural drop, had no tachycardia and there was no hypertensive retinopathy. Investigations including routine blood biochemistry, thyroid stimulating hormone, blood count, ECG, echocardiogram, 24-h ambulatory BP profile, MRI of the adrenal glands, and 24-h urinary levels of 5-HIAA, noradrenaline, adrenaline and dopamine were all normal.
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A pentolinium suppression test was performed. Venous blood, for measurement of plasma catecholamines, was taken immediately prior to intravenous injection of 2.5 mg of pentolinium and 30 min later. BP and pulse were monitored throughout and remained stable. One hour later she suffered an attack of her classical symptoms when she was observed to be flushed, agitated, thirsty and polyuric. Her BP rose to 148/98 mm Hg, and her heart rate to 84 beats per minute. A further blood sample was taken shortly after the onset of these symptoms. Minimally elevated baseline catecholamines showed a normal response to pentolinium (Figure 1 ). During the attack there was a moderate rise in plasma noradrenaline and adrenaline and plasma dopamine levels rose more than 20-fold. Subsequent multiple-site venous sampling, performed to exclude a dopamine-secreting tumour, showed a normal distribution of plasma noradrenaline, adrenaline and dopamine levels. The patient was initiated on a beta-blocker (atenolol 50 mg daily) and discharged with confidence that a phaeochromocytoma had been excluded. Since starting a beta-blocker, her symptoms have resolved.
In 1935, Page described a group of women with paroxysmal hypertension and symptoms similar to those described by our patient, notably flushing, sweating and tachycardia. 1 He attributed the symptoms to irritation of the sympathetic and parasympathetic centres in the diencephalon. In 1986, Kuchel reported a series of patients, predominantly women, whose plasma dopamine levels increased up to 16-fold during attacks similar to those described by Figure 1 Plasma measurements of noradrenaline, adrenaline and dopamine, before and after intravenous injection of pentolinium and one hour later during an 'attack'.
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2 This may represent an atypical sympathetic discharge, stimulated by emotional factors, during which dopamine release exceeds that of noradrenaline and adrenaline. Elevated dopamine levels are unlikely to be responsible for the hypertension as infusing dopamine to similar levels failed to significantly raise BP. 3 However flushing may be directly attributable to the vasodilator effects of dopamine and polyuria to a renal dopaminergic action. 4 Hypertension may result from anxiety induced by these symptoms. Treatment has been advocated with beta-blockade alone or with centrally-acting sympathetic inhibitors 5 although, owing to the small numbers of patients, no systematic studies have been done.
In conclusion we have reported a case of Page's Syndrome or pseudophaeochromocytoma. Although her symptoms, notably flushing, were not typical of phaeochromocytoma, plasma catecholamine measurement during an attack was instrumental in making the distinction. Marked similarities exist between Page's Syndrome and panic attacks. This raises the intriguing question as to whether dopamine may be a biochemical mediator for some of the symptoms in panic disorder and indeed whether, as Page speculated, spontaneous diencephalic discharges, influencing autonomic outflow from the brain stem, may underlie these phenomena in some patients. Despite an extensive literature search, we have been unable to find any data on the subject of dopamine levels in panic disorder.
